About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Docs on Twitter


Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« WRG Webinar on New Continuation and Claims Rules | Main | Conference & CLE Calendar »

September 21, 2007

BMS and Exelixis Extend Agreement

    By Jason Derry --

Exelixis_logo_2 Exelixis and Bristol-Myers Squibb have announced an agreement to extend their research collaboration relating to cardiovascular and metabolic diseases for an additional year, now ending in January 2009.  Under the terms of the extension, Exelixis will receive an additional $7.5 million in funding.  The collaboration is focused on developing therapies against the Liver X Receptor (LXR).  The companies hope to discover and develop drug candidates that will activate LXR, which may cause removal of cholesterol from the body and also suppression of inflammatory responses associated with atherosclerosis.

Bristolmyers_squibb_1

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 11:17 PM in Licensing |

Comments

The comments to this entry are closed.

January 2023

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31        

Categories

Archives

More...